Background & objective
Chronic kidney disease (CKD) is a common condition in worldwide with underlying causes. The role of trace elements such as copper and zinc in CKD is uncertain. We aimed to examine the relationship of serum copper and zinc with kidney function status and explore its possible effect modifiers in the general population.
Data from 5353 National Health and Nutrition Examination Survey (NHANES) participants from 2011 to 2016 were analyzed for the role of trace elements in the age range 18 to 80 years. The kidney outcomes were reduced estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 and increased urinary albumin-to-creatinine ratio (ACR) ≥ 30 mg/g.
Findings showed a significant positive association between serum copper and urinary ACR (OR = 1.04, 95% CI = 1.00–1.07). Serum copper levels of 18.0 μmol/L (median) or higher (reference level <18.0 μmol/L) were significantly associated with increased urinary ACR (OR = 1.67, 95% CI = 1.21–2.31) after adjusting for confounding factors. In contrast, there was a significant inverse association between serum zinc and reduced eGFR (OR = 0.89,95% CI = 0.81–0.99). Where serum zinc level was greater than 12.3 μmol/L (median), the prevalence of reduced eGFR was lower (OR = 0.65, 95% CI = 0.16–0.60). In addition, a stratified analysis based on various risk factors found that in those individuals with serum albumin greater than 43 g/L or systolic blood pressure greater than 120 mmHg, positive correlations between serum copper and risk of increased urinary ACR was more significant.
Our findings suggest that the reference levels of serum copper and zinc levels in healthy individuals may be different from current understanding. If further studies substantiate the same, the results will be a useful guide for designing future clinical trials and nutritional guidelines.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
The datasets analysed during the current study are available in the National Health and Nutrition Examination Survey repository, [https://wwwn.cdc.gov/nchs/nhanes].
Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88:950–7.
Stevens PE, Levin A. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.
Huan L, Yuezhong L, Chao W, HaiTao T. The urine albumin-to-creatinine ratio is a reliable indicator for evaluating complications of chronic kidney disease and progression in IgA nephropathy in China. Clinics. 2016;71:243–50.
Liu S, Niu J, Wu S, Xin Z, Zhao Z, Xu M, et al. Urinary albumin-to-creatinine ratio levels are associated with subclinical atherosclerosis and predict CVD events and all-cause deaths: A prospective analysis. BMJ Open. 2021;11:e40890.
Chang DR, Yeh HC, Ting IW, Lin CY, Huang HC, Chiang HY, et al. The ratio and difference of urine protein-to-creatinine ratio and albumin-to-creatinine ratio facilitate risk prediction of all-cause mortality. Sci Rep. 2021;11:7851.
Strain JJ. Newer aspects of micronutrients in chronic disease: Copper. Proc Nutr Soc. 1994;53:583–98.
Linder MC, Hazegh-Azam. M. Copper biochemistry and molecular biology. Am J Clin Nutr. 1996;63:797S–811S.
Chen A, Li G, Liu. Y. Association between copper levels and myocardial infarction: A meta-analysis. Inhal Toxicol. 2015;27:237–46.
Ebara M, Fukuda H, Hatano R, Saisho H, Nagato Y, Suzuki K, et al. Relationship between copper, zinc, and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J Hepatol. 2000;33:415–22.
Grammer TB, Kleber ME, Silbernagel G, Pilz S, Scharnagl H, Lerchbaum E, et al. Copper, ceruloplasmin, and long-term cardiovascular and total mortality (the Ludwigshafen Risk and Cardiovascular Health Study). Free Radic Res. 2014;48:706–15.
King JC. Zinc: An essential but elusive nutrient. Am J Clin Nutr. 2011;94:679S–84S.
Prasad AS. Zinc: An antioxidant and anti-inflammatory agent: Role of zinc in degenerative disorders of aging. J Trace Elem Med Biol. 2014;28:364–71.
Roney N, Osier M, Paikoff SJ, Smith CV, Williams M, De Rosa. CT. ATSDR evaluation of the health effects of zinc and relevance to public health. Toxicol Ind Health. 2006;22:423–93.
Tsuboi A, Terazawa WM, Kazumi T, Fukuo K. Serum copper, zinc and risk factors for cardiovascular disease in community-living Japanese elderly women. Asia Pac J Clin Nutr. 2014;23:239–45.
Freitas EP, Cunha AT, Aquino SL, Pedrosa LF, Lima SC, Lima JG, et al. Zinc status biomarkers and cardiometabolic risk factors in metabolic syndrome: A case-control study. Nutrients. 2017;9:175.
Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. https://www.cdc.gov/nchs/nhanes/index.htm.
Kobayashi K, Katsuya Y, Abdulah R, Koyama. H. Rapid and direct determination of selenium, copper, and zinc in blood plasma by flow injection-inductively coupled plasma-mass spectrometry. Biol Trace Elem Res. 2007;115:87–93.
National Health and Nutrition Examination Survey 2011-2012 Data Documentation, Codebook, and Frequencies. Copper, Selenium & Zinc - Serum (CUSEZN_G). https://wwwn.cdc.gov/Nchs/Nhanes/2011-2012/CUSEZN_G.htm.
National Health and Nutrition Examination Survey 2013-2014 Data Documentation, Codebook, and Frequencies. Copper, Selenium & Zinc - Serum (CUSEZN_H). https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/CUSEZN_H.htm.
National Health and Nutrition Examination Survey. NHANES 2011-2012 Laboratory Methods. https://wwwn.cdc.gov/nchs/data/nhanes/2011-2012/labmethods/CUSEZN_G_met_serum_elements.pdf.
National Health and Nutrition Examination Survey. 2017_MEC_Laboratory_Procedures_Manual. https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/manuals/2016_MEC_Laboratory_Procedures_Manual.pdf.
National Health and Nutrition Examination Survey 2015-2016 Data Documentation, Codebook, and Frequencies. Copper, Selenium & Zinc - Serum (CUSEZN_I). https://wwwn.cdc.gov/Nchs/Nhanes/2015-2016/CUSEZN_I.htm.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AR, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Shen Y, Yin Z, Lv Y, Luo J, Shi W, Fang J, et al. Plasma element levels and risk of chronic kidney disease in elderly populations (≥90 Years old). Chemosphere 2020;254:126809.
Makhlough A, Makhlough M, Shokrzadeh M, Mohammadian M, Sedighi O, Faghihan M. Comparing the levels of trace elements in patients with diabetic nephropathy and healthy individuals. Nephrourol Mon. 2015;7:e28576.
Liu X, Zhao Y, Feng. Y. Estimation of 24-h urine protein excretion using urine albumin-to-creatinine ratio from an in-hospital population. Med Sci Monit. 2022;28:e934307.
Yang F, Yi X, Guo J, Xu S, Xiao Y, Huang X, et al. Association of plasma and urine metals levels with kidney function: A population-based cross-sectional study in China. Chemosphere 2019;226:321–8.
Brewer GJ. Risks of copper and iron toxicity during aging in humans. Chem Res Toxicol. 2010;23:319–26.
de Romana DL, Olivares M, Uauy R, Araya. M. Risks and benefits of copper in light of new insights of copper homeostasis. J Trace Elem Med Biol. 2011;25:3–13.
Gaetke LM, Chow-Johnson HS, Chow. CK. Copper: Toxicological relevance and mechanisms. Arch Toxicol. 2014;88:1929–38.
Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003;189:147–63.
Pereira TC, Campos MM, Bogo. MR. Copper toxicology, oxidative stress, and inflammation using zebrafish as experimental model. J Appl Toxicol. 2016;36:876–85.
Uriu-Adams JY, Keen. CL. Copper, oxidative stress, and human health. Mol Asp Med. 2005;26:268–98.
Baltaci AK, Yuce K, Mogulkoc. R. Zinc metabolism and metallothioneins. Biol Trace Elem Res. 2018;183:22–31.
Hambidge M, Krebs. NF. Zinc metabolism and requirements. Food Nutr Bull. 2001;22:126–32.
Wastney ME, House WA, Barnes RM, Subramanian KN. Kinetics of zinc metabolism: Variation with diet, genetics and disease. J Nutr. 2000;130(5S Suppl):1355S–9S.
Mocchegiani E, Giacconi R, Muzzioli M, Cipriano. C. Zinc, infections and immunosenescence. Mech Ageing Dev. 2000;121:21–35.
Mocchegiani E, Muzzioli M, Giacconi. R. Zinc and immunoresistance to infection in aging: New biological tools. Trends Pharm Sci. 2000;21:205–08.
Maruyama Y, Nakashima A, Fukui A, Yokoo. T. Zinc deficiency: Its prevalence and relationship to renal function in Japan. Clin Exp Nephrol 2021;25:771–8.
Ye M, Li G, Yan P, Ren J, Zheng L, Han D, et al. Removal of metals from lead-zinc mine tailings using bioleaching and followed by sulfide precipitation. Chemosphere 2017;185:1189–96.
Lezaic V, Ristic S, Dopsaj V, Marinkovic. J. Is morning urinary protein-to-creatinine ratio a reliable estimator of 24-hour proteinuria in patients with kidney diseases? SRP Arh Celok Lek. 2010;138:726–31.
The authors thank the investigators and participants of the National Health and Nutrition Examination Survey, which made this report possible.
This work was supported by High Level-Hospital Program, Health Commission of Guangdong Province, China (HKUSZH20192026).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Jiang, C., Ye, H., Cui, L. et al. Relationship of serum copper and zinc with kidney function and urinary albumin to creatinine ratio: Cross-sectional data from the NHANES 2011–2016. Eur J Clin Nutr (2022). https://doi.org/10.1038/s41430-022-01181-8